Search

everythinglearnresearchcommunity

for

Search:↓

Applying valproic acid on the scalp increased hair growth in men with hair loss.

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

Hair loss at the top of the head is linked to prostate cancer, but other types of hair loss are not.

Mrp3 may aid in wound healing and hair growth.

Mrp3 helps in wound healing and hair growth.

The scant hair in snthr-1Bao mice is likely caused by a deletion affecting the Plcd1 gene.

Dermatologists perform most outpatient cosmetic procedures in the U.S., especially on white women aged 40 to 59.

Dermatologists performed the most outpatient cosmetic procedures in the U.S. from 1995 to 2003, especially on white women aged 40 to 59.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

FUE effectively corrects poorly designed hairlines in men with androgenetic alopecia.

Matriptase-2 helps control iron levels by suppressing hepcidin, and its deficiency can cause iron-deficiency anemia.

MsPG3 protein gathers at root hair tips, aiding growth.

miRNAs in the Dlk1-Gtl2 region may improve lamb fur quality.

MPA increases cancer spread by boosting Eph A2 activity.

Dicer is crucial for hair growth in mice.

A protein called PCBP2 controls the production of a hair growth protein by interacting with its genetic message and is linked to hair loss when this control is disrupted.

A 4kb fragment of the desmocollin 3 promoter targets gene expression to specific skin and hair follicle areas.

A specific RNA molecule blocks hair growth by affecting a protein related to hair loss conditions.

AL136131.3 slows hair growth by affecting energy processes in hair loss.

Hair follicle samples effectively show how well the drug MK-0752 targets and engages with the Notch pathway.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

The MtAnn3 gene affects root hair growth and is influenced by cytokinin.

A new genetic region, 17q21.31, is linked to higher ovarian cancer risk.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

Overexpressing NSD3 in mice causes breast cancer-like tumors and gland abnormalities.